BACKGROUND. Restriction of dietary protein may slow the progression of renal failure in diverse renal diseases, but the extent to which such a diet is beneficial in patients with diabetic nephropathy is uncertain. METHODS. We studied the effect of reduced intake of protein and phosphorus on the progression of renal disease in 35 patients with insulin-dependent (Type I) diabetes mellitus and clinically evident nephropathy. The low-protein, low-phosphorus diet contained 0.6 g of protein per kilogram of ideal body weight per day, 500 to 1000 mg of phosphorus, and 2000 mg of sodium. The control diet consisted of the patient's prestudy diet with the stipulation that it contain 2000 mg of sodium and at least 1 g of protein per kilogram per day and 1000 mg of phosphorus. Renal function was assessed by measurement of iothalamate and creatinine clearances at intervals of 3 to 6 months, and the patients were followed for a minimum of 12 months (mean, 34.7). The declines in mean glomerular filtration rates were compared between groups by linear-regression analysis of the glomerular filtration rate as a function of time. RESULTS. The patients who followed the study diet for a mean of 37.1 months had declines in iothalamate clearance of 0.0043 ml per second per month and in creatinine clearance of 0.0055 ml per second per month. The comparable values in the control group were 0.0168 and 0.0135, respectively (P less than 0.05). Blood pressure was well controlled, and the degree of glycemic control was comparable in both groups. CONCLUSION. Dietary restriction of protein and phosphorus can retard the progression of renal failure in patients with Type I diabetes mellitus who have nephropathy. We believe that wider use of this treatment is indicated.
Source Information
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8889.
This article has been cited by other articles:
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., Krolewski, A. S.
(2007). Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes. J. Am. Soc. Nephrol.
18: 1353-1361
[Abstract][Full Text]
Franz, M. J.
(2006). Medical Nutrition Therapy for Hypertension and Albuminuria. Diabetes Spectr.
19: 32-38
[Abstract][Full Text]
Joss, N., Ferguson, C., Brown, C., Deighan, C.J., Paterson, K.R., Boulton-Jones, J.M.
(2004). Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy. QJM
97: 219-227
[Abstract][Full Text]
Loon, N. R.
(2003). Diabetic Kidney Disease: Preventing Dialysis and Transplantation. Clin. Diabetes
21: 55-62
[Abstract][Full Text]
Bonow, R. O., Mitch, W. E., Nesto, R. W., O'Gara, P. T., Becker, R. C., Clark, L. T., Hunt, S., Jialal, I., Lipshultz, S. E., Loh, E.
(2002). Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications. Circulation
105
: e159-e164
[Full Text]
Nathan, D. M.
(2002). The Impact of Clinical Trials on the Treatment of Diabetes Mellitus. J. Clin. Endocrinol. Metab.
87: 1929-1937
[Abstract][Full Text]
Remuzzi, G., Schieppati, A., Ruggenenti, P.
(2002). Nephropathy in Patients with Type 2 Diabetes. NEJM
346: 1145-1151
[Full Text]
Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., Purnell, J. Q., Wheeler, M.
(2002). Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes Care
25: 148-198
[Full Text]
Tuttle, K. R., Puhlman, M. E., Cooney, S. K., Short, R. A.
(2002). Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes. Am. J. Physiol. Renal Physiol.
282: F103-F112
[Abstract][Full Text]
Möllsten, A. V., Dahlquist, G. G., Stattin, E.-L., Rudberg, S.
(2001). Higher Intakes of Fish Protein Are Related to a Lower Risk of Microalbuminuria in Young Swedish Type 1 Diabetic Patients. Diabetes Care
24: 805-810
[Abstract][Full Text]
Brenner, B. M, Cooper, M. E, de Zeeuw, D., Grunfeld, J.-P., Keane, W. F, Kurokawa, K., McGill, J. B, Mitch, W. E, Parving, H. H., Remuzzi, G., Ribeiro, A. B, Schluchter, M. D, Snavely, D., Zhang, Z., Simpson, R., Ramjit, D., Shahinfar, S., RENAAL Study Investigators,
(2000). The losartan renal protection study -- rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). Journal of Renin-Angiotensin-Aldosterone System
1: 328-335
[Abstract]
Ritz, E., Orth, S. R.
(1999). Nephropathy in Patients with Type 2 Diabetes Mellitus. NEJM
341: 1127-1133
[Full Text]
Anderson, J. W, Smith, B. M, Washnock, C. S
(1999). Cardiovascular and renal benefits of dry bean and soybean intake. Am. J. Clin. Nutr.
70: 464S-474
[Abstract][Full Text]
Feest, T.G., Dunn, E.J., Burton, C.J.
(1999). Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?. QJM
92: 275-282
[Abstract][Full Text]
Rahman, M., Smith, M. C.
(1998). Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach. Arch Intern Med
158: 1743-1752
[Abstract][Full Text]
Brodsky, I. G.
(1998). Nutritional Effects of Dietary Protein Restriction in Insulin-Dependent Diabetes Mellitus. J. Nutr.
128: 337-337
[Abstract][Full Text]
Franz, M. J.
(1997). Protein, Diabetes, and Nephropathy. The Diabetes Educator
23: 535-543
Clark, C. M., Lee, D. A.
(1995). Prevention and Treatment of the Complications of Diabetes Mellitus. NEJM
332: 1210-1217
[Full Text]
Nathan, D. M.
(1993). Long-Term Complications of Diabetes Mellitus. NEJM
328: 1676-1685
[Full Text]
(1991). DIETARY PROTEIN RESTRICTION SLOWS PROGRESSION OF DIABETIC NEPHROPATHY. JWatch General
1991: 1-1
[Full Text]
Previous
